Wine and drug evaluations: lessons on making comparisons of noninferiority.
Allgulander
C
C
Nutt
D  J
D
D001008:Anxiety Disorders / Q000188:drug therapy; D003431:Cross-Cultural Comparison; D003511:Cyclohexanols / Q000592:standards* / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D000068736:Duloxetine Hydrochloride; D005060:Europe; D006801:Humans; D015990:Placebo Effect; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D017367:Selective Serotonin Reuptake Inhibitors / Q000592:standards* / Q000627:therapeutic use; D013876:Thiophenes / Q000592:standards* / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence; D000069470:Venlafaxine Hydrochloride; D014920:Wine / Q000592:standards*
D003511:Cyclohexanols; D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes; D000069470:Venlafaxine Hydrochloride